Bespoke Extracts (BSPK) Cash from Investing Activities Growth (3y) (2016 - 2017)

Bespoke Extracts (BSPK) Cash from Investing Activities Growth (3y) (2016 - 2017) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 8.16%
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 26.15%
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 51.85%
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 75.05%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 33.33%
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -129.09%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -2.94%
10 Bespoke Extracts 1.12 Mn 1.11 Mn 234,175.00 -

Historic Data

Download Data
DateValue
May 31, 2017 64.15%
Aug 31, 2016 33.01%